London · Delayed Price · Currency is GBP · Price in GBX Physiomics Statistics
Total Valuation
Physiomics has a market cap or net worth of GBP 2.04 million. The enterprise value is 1.62 million.
| Market Cap | 2.04M |
| Enterprise Value | 1.62M |
Important Dates
The next estimated earnings date is Monday, November 16, 2026.
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Physiomics has 453.21 million shares outstanding. The number of shares has increased by 41.46% in one year.
| Current Share Class | 453.21M |
| Shares Outstanding | 453.21M |
| Shares Change (YoY) | +41.46% |
| Shares Change (QoQ) | +27.92% |
| Owned by Insiders (%) | 31.71% |
| Owned by Institutions (%) | 46.92% |
| Float | 304.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.04 |
| PB Ratio | 4.11 |
| P/TBV Ratio | 4.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.88
| Current Ratio | 2.88 |
| Quick Ratio | 2.27 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,211.02 |
Financial Efficiency
Return on equity (ROE) is -114.63% and return on invested capital (ROIC) is -70.45%.
| Return on Equity (ROE) | -114.63% |
| Return on Assets (ROA) | -50.98% |
| Return on Invested Capital (ROIC) | -70.45% |
| Return on Capital Employed (ROCE) | -130.81% |
| Weighted Average Cost of Capital (WACC) | 9.90% |
| Revenue Per Employee | 95,924 |
| Profits Per Employee | -63,367 |
| Employee Count | 10 |
| Asset Turnover | 1.26 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Physiomics has paid 10,325 in taxes.
| Income Tax | 10,325 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.65% in the last 52 weeks. The beta is 1.03, so Physiomics's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | +4.65% |
| 50-Day Moving Average | 0.50 |
| 200-Day Moving Average | 0.49 |
| Relative Strength Index (RSI) | 32.03 |
| Average Volume (20 Days) | 3,407,868 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Physiomics had revenue of GBP 1.06 million and -697,034 in losses. Loss per share was -0.00.
| Revenue | 1.06M |
| Gross Profit | -651,542 |
| Operating Income | -685,435 |
| Pretax Income | -686,709 |
| Net Income | -697,034 |
| EBITDA | -676,542 |
| EBIT | -685,435 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 418,635 in cash and no debt, with a net cash position of 418,635 or 0.00 per share.
| Cash & Cash Equivalents | 418,635 |
| Total Debt | n/a |
| Net Cash | 418,635 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 523,977 |
| Book Value Per Share | 0.00 |
| Working Capital | 496,419 |
Cash Flow
In the last 12 months, operating cash flow was -562,852 and capital expenditures -4,426, giving a free cash flow of -567,278.
| Operating Cash Flow | -562,852 |
| Capital Expenditures | -4,426 |
| Depreciation & Amortization | 8,893 |
| Net Borrowing | n/a |
| Free Cash Flow | -567,278 |
| FCF Per Share | -0.00 |
Margins
Gross margin is -61.75%, with operating and profit margins of -64.96% and -66.06%.
| Gross Margin | -61.75% |
| Operating Margin | -64.96% |
| Pretax Margin | -65.08% |
| Profit Margin | -66.06% |
| EBITDA Margin | -64.12% |
| EBIT Margin | -64.96% |
| FCF Margin | n/a |
Dividends & Yields
Physiomics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -41.46% |
| Shareholder Yield | -41.46% |
| Earnings Yield | -32.38% |
| FCF Yield | -26.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 19, 2016. It was a reverse split with a ratio of 0.01.
| Last Split Date | Dec 19, 2016 |
| Split Type | Reverse |
| Split Ratio | 0.01 |
Scores
Physiomics has an Altman Z-Score of -12.29 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.29 |
| Piotroski F-Score | 1 |